2016 Q2 Form 10-Q Financial Statement

#000114420416100436 Filed on May 10, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2016 Q1 2015 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $4.737M $4.628M $4.705M
YoY Change
Gross Profit -$4.737M -$4.628M -$4.705M
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.211M $281.2K $724.5K
YoY Change -36.11% 44.16% 425.09%
Operating Profit -$1.211M -$281.2K -$5.430M
YoY Change -36.11% 44.16%
Interest Expense $30.00K $30.00K $0.00
YoY Change 200.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.180M -$250.0K -$730.0K
YoY Change -37.57% 31.58% 421.43%
Income Tax
% Of Pretax Income
Net Earnings -$1.176M -$246.4K -$728.5K
YoY Change -37.78% 32.25% 427.99%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$388.2K -$83.06K -$248.3K
COMMON SHARES
Basic Shares Outstanding 10.00M shares 10.00M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q2 2016 Q1 2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $200.0K $500.0K $300.0K
YoY Change -71.43% -44.44% -72.73%
Cash & Equivalents $200.0K $520.0K $256.2K
Short-Term Investments
Other Short-Term Assets $100.0K $100.0K $100.0K
YoY Change 0.0% -50.0%
Inventory
Prepaid Expenses $137.9K $62.59K
Receivables
Other Receivables
Total Short-Term Assets $300.0K $657.8K $318.8K
YoY Change -63.7% -26.91% -75.24%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $80.00M $80.00M $80.00M
YoY Change 0.0% -0.12% 0.0%
Total Long-Term Assets $80.00M $80.05M $80.01M
YoY Change -0.03% -0.19% 0.0%
TOTAL ASSETS
Total Short-Term Assets $300.0K $657.8K $318.8K
Total Long-Term Assets $80.00M $80.05M $80.01M
Total Assets $80.30M $80.70M $80.33M
YoY Change -0.68% -0.49% -1.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.500M $2.800M $2.600M
YoY Change 105.88% 2500.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.000M $3.266M $2.646M
YoY Change 133.38% 2983.94%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.800M $2.800M $2.800M
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Liabilities $2.800M $2.800M $2.800M
YoY Change 0.0% 0.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.000M $3.266M $2.646M
Total Long-Term Liabilities $2.800M $2.800M $2.800M
Total Liabilities $6.800M $6.066M $5.446M
YoY Change 50.64% 116.63% 88.71%
SHAREHOLDERS EQUITY
Retained Earnings -$3.914M -$3.668M
YoY Change 1093.99% 2491.51%
Common Stock $304.00 $301.00
YoY Change 13.43% 13.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $73.50M $5.000M $5.000M
YoY Change
Total Liabilities & Shareholders Equity $80.30M $80.70M $80.33M
YoY Change -0.68% -0.43% -1.19%

Cashflow Statement

Concept 2016 Q2 2016 Q1 2015 Q4
OPERATING ACTIVITIES
Net Income -$1.176M -$246.4K -$728.5K
YoY Change -37.78% 32.25% 427.99%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$350.0K -$240.0K -$150.0K
YoY Change -16.67% -7.69% 7.14%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $50.00K $0.00
YoY Change -100.0%
Cash From Investing Activities $50.00K $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 500.0K 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -350.0K -240.0K -150.0K
Cash From Investing Activities 50.00K 0.000
Cash From Financing Activities 0.000 500.0K 0.000
Net Change In Cash -300.0K 260.0K -150.0K
YoY Change -28.57% -200.0% -114.02%
FREE CASH FLOW
Cash From Operating Activities -$350.0K -$240.0K -$150.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2016Q1 dei Trading Symbol
TradingSymbol
HDRAU
CY2016Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10000000 shares
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
519976 USD
CY2016Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
137851 USD
CY2015Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
62589 USD
CY2016Q1 us-gaap Assets Current
AssetsCurrent
657827 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
318828 USD
CY2016Q1 us-gaap Other Assets
OtherAssets
1050 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
256239 USD
CY2015Q4 us-gaap Other Assets
OtherAssets
1500 USD
CY2015Q4 us-gaap Assets
Assets
80329807 USD
CY2016Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2765618 USD
CY2015Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2645838 USD
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
281231 USD
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
195089 USD
CY2016Q1 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
80044350 USD
CY2015Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
80009479 USD
CY2016Q1 us-gaap Assets
Assets
80703227 USD
CY2016Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3265618 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2645838 USD
CY2016Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2800000 USD
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2800000 USD
CY2016Q1 us-gaap Liabilities
Liabilities
6065618 USD
CY2015Q4 us-gaap Liabilities
Liabilities
5445838 USD
CY2016Q1 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
69637608 USD
CY2015Q4 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
69883968 USD
CY2016Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q1 us-gaap Common Stock Value
CommonStockValue
304 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
301 USD
CY2016Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8913792 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8667435 USD
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3914095 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3667735 USD
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
5000001 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
5000001 USD
CY2016Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
80703227 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
80329807 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
500000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-109 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-281231 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-195089 USD
CY2016Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
21174 USD
CY2015Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
8802 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-246360 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-186287 USD
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3012432 shares
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2658983 shares
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2016Q1 us-gaap Held To Maturity Securities Unrecognized Holding Gains
HeldToMaturitySecuritiesUnrecognizedHoldingGains
13697 USD
CY2015Q1 us-gaap Held To Maturity Securities Unrecognized Holding Gains
HeldToMaturitySecuritiesUnrecognizedHoldingGains
0 USD
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
75262 USD
CY2016Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-450 USD
CY2015Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-20892 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
119780 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-55685 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-236263 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-255747 USD
CY2016Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 USD
CY2015Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
109 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
263737 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-255856 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1123278 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
867422 USD
CY2016Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
6618 USD
CY2015Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
6021 USD
CY2016Q1 hdrau Payment Of Offering Costs And Operational Costs Pursuant To Related Party Advances
PaymentOfOfferingCostsAndOperationalCostsPursuantToRelatedPartyAdvances
0 USD
CY2015Q1 hdrau Payment Of Offering Costs And Operational Costs Pursuant To Related Party Advances
PaymentOfOfferingCostsAndOperationalCostsPursuantToRelatedPartyAdvances
44 USD
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
25865 USD
CY2014Q4 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
80000000 USD
CY2014Q4 us-gaap Share Price
SharePrice
10.00
CY2014Q4 hdrau Cash Available For Fund Operations
CashAvailableForFundOperations
1326704 USD
CY2016Q1 hdrau Working Capital
WorkingCapital
2607791 USD
CY2016Q1 us-gaap Interest Income Domestic Deposits
InterestIncomeDomesticDeposits
35694 USD
CY2016Q1 us-gaap Line Of Credit Facility Capacity Available For Specific Purpose Other Than For Trade Purchases
LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases
250000 USD
CY2016Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
500000 USD
CY2016Q1 hdrau Common Stock Redemption Shares
CommonStockRedemptionShares
6959902 shares
CY2015Q4 hdrau Common Stock Redemption Shares
CommonStockRedemptionShares
6987568 shares
CY2016Q1 hdrau Federal Depository Insurance Coverage
FederalDepositoryInsuranceCoverage
250000 USD
CY2016Q1 hdrau Underwriting Discount Percentage
UnderwritingDiscountPercentage
0.060 pure
CY2016Q1 hdrau Underwriting Discount Paid In Cash Percentage
UnderwritingDiscountPaidInCashPercentage
0.025 pure
CY2016Q1 us-gaap Payments For Underwriting Expense
PaymentsForUnderwritingExpense
2000000 USD
CY2014Q4 hdrau Underwriting Discount Differed Percentage
UnderwritingDiscountDifferedPercentage
0.035 pure
CY2014Q4 hdrau Underwriting Discount Differed Amount
UnderwritingDiscountDifferedAmount
2800000 USD
CY2016Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2016Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
29000000 shares
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3040098 shares
CY2016Q1 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
500000 USD
CY2015Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
0 USD
CY2016Q1 hdrau Common Stock Subject To Redemption Shares
CommonStockSubjectToRedemptionShares
6959902 shares
CY2015Q1 hdrau Common Stock Subject To Redemption Shares
CommonStockSubjectToRedemptionShares
7322388 shares
CY2016Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
500000 USD
CY2015Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
CY2016Q1 hdrau Change In Value Of Common Stock Subject To Possible Redemption
ChangeInValueOfCommonStockSubjectToPossibleRedemption
246360 USD
CY2015Q1 hdrau Change In Value Of Common Stock Subject To Possible Redemption
ChangeInValueOfCommonStockSubjectToPossibleRedemption
186290 USD
CY2014Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
250000 USD
CY2016Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
500000 USD
CY2016Q1 hdrau Liquidation Condition
LiquidationCondition
If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering (the Combination Period), the Company will (i) cease all operations except for the purposes of winding up its affairs; (ii) distribute the aggregate amount then on deposit in the Trust Account, including a portion of the interest earned thereon (net of any taxes payable, and less up to $50,000 of interest to pay dissolution expenses), pro rata to the Companys public stockholders by way of redemption of the Companys public shares (which redemption would completely extinguish such holders rights as stockholders, including the right to receive further liquidation distributions, if any); and (iii) as promptly as possible following such redemption, dissolve and liquidate the balance of the Companys net assets to its remaining stockholders, as part of the Companys plan of dissolution and liquidation.
CY2016Q1 us-gaap Share Price
SharePrice
10.00
CY2016Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-SIZE: 10pt">Use of estimates</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future events. Accordingly, the actual results could differ significantly from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q1 hdrau Minimum Value Of Net Tangible Assets Shares Redeemed
MinimumValueOfNetTangibleAssetsSharesRedeemed
5000001 USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-SIZE: 10pt">Concentration of credit risk</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times may exceed the Federal depository insurance coverage of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">250,000</font>. At March 31, 2016, the Company had not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
500000 USD
CY2016Q1 hdrau Minimum Fair Market Value Of Target Business As Percentage Of Assets Held In Trust
MinimumFairMarketValueOfTargetBusinessAsPercentageOfAssetsHeldInTrust
0.8 pure
CY2016Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
29000000 shares
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3040098 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3012432 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3012432 shares

Files In Submission

Name View Source Status
0001144204-16-100436-index-headers.html Edgar Link pending
0001144204-16-100436-index.html Edgar Link pending
0001144204-16-100436.txt Edgar Link pending
0001144204-16-100436-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hdrau-20160331.xml Edgar Link completed
hdrau-20160331.xsd Edgar Link pending
hdrau-20160331_cal.xml Edgar Link unprocessable
hdrau-20160331_def.xml Edgar Link unprocessable
hdrau-20160331_lab.xml Edgar Link unprocessable
hdrau-20160331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v438857_10q.htm Edgar Link pending
v438857_ex31-1.htm Edgar Link pending
v438857_ex31-2.htm Edgar Link pending
v438857_ex32-1.htm Edgar Link pending
v438857_ex32-2.htm Edgar Link pending